What’s new at Hadasit

News
January 10, 2024

Register for 17.01.24 Smart Hospital: Digital Infrastructure and Patient Data Collaborations

News
November 27, 2023

Protected: CD59 as a Target for Treating Fatty Liver, NASH, Glucose Intolerance, and Peripheral Insulin Resistance

News
June 26, 2023

Immunyx Pharma won 1st place in Catapult competition of the EIT Health

News
June 15, 2023

Hadassah Center for Psychedelic Research: Psilocybin Could Be Effective OCD Treatment

News
June 14, 2023

EMRIS Pharma Launches the Development of a New Innovative topical drug for the Treatment of Skin Toxicities

News
May 05, 2023

Pathkeeper received FDA clearance for the spinal surgery navigation system

News
April 25, 2023

Israeli universities and hospitals churn out startups as ties with tech industry grow

News
April 24, 2023

Hadasit’s portfolio company NeuroGenesis receives FDA clearance for Phase IIb study

News
April 18, 2023

Gamida Cell receives FDA approval for blood cancer therapy, developed in collaboration with Prof. Amnon Peled, Hadassah

News
March 21, 2023

P-Cure’s Prothon therapy deployed in collaboration with Hadassah Medical Center received FDA clearance

News
January 23, 2023

Hadassah Portfolio Company Immunyx Pharma Selected to Join BLUE KNIGHT™

News
December 02, 2022

Hadassah scientists derived male and female cells from same person for the first time in the world

News
October 20, 2022

Exosomm reaches Calcalist and Tnuva’s FoodTech competition final stage

News
August 17, 2022

Hadasit portfolio company Enlivex Therapeutics has received approval for initiation the multicenter Phase I/II Trial of Allocetra

News
March 08, 2022

Promising results of the novel cell therapy against progressive Multiple Sclerosis in its latest clinical trial

News
March 01, 2022

Hadassah Digital Health Accelerator Cohort 4 Graduation

News
December 21, 2021

רוש רוכשת מליניאג’ את זכויות הפיתוח והשיווק של סלקיור

News
December 20, 2021

Lineage Establishes Exclusive Worldwide Collaboration With Genentech for the Development and Commercialization of OpRegen® RPE Cell Therapy for the Treatment of Ocular Disorders

News
October 11, 2021

Three Israeli hospitals make Newsweek’s list of top cardiology centers

News
August 29, 2021

Hadassah, Hebrew University and SHL collaboration for developing AI tools in telemedicine

News
August 29, 2021

Israel’s BrainWatch Tech is working on prototype of device that will automatically measure and record pupillary reactions to light in patients with severe brain injury

News
June 06, 2021

KAHR Announces $46.5 Million Financing to Advance its Multifunctional Immunotherapeutic Pipeline

News
June 02, 2021

היסטוריה בהדסה: מנהל אגף נשים ויולדות בבית החולים זכה בפרס היוקרתי בעולם בתחומו

News
April 06, 2021

Hadassah and MyBiotics to Collaborate for the Discovery of Microbiome-Based Therapy for Improving Cancer Immunotherapy

News
February 10, 2021

פיתוח חדש יאפשר לראשונה מעקב בזמן אמת במהלך ניתוחי מוח מורכבים

News
November 01, 2020

ניסוי ניוד תאי הגזע של ביוליין הצליח – והמניה נוסקת

News
February 26, 2020

Cancer treatment co Kahr Medical raises $18m

News
October 29, 2019

Wohl Institute for Translational Medicine Inaugurated at Hadassah Medical Organization in Jerusalem

News
October 01, 2019

הדסה וחברת י.ב.מ מקימים אקסלרטור בריאות דיגיטלית

News
October 01, 2019

Hadassah Accelerator

News
August 11, 2019

Startup Nobio gets FDA nod for antibacterial dental fillings

News
July 21, 2019

ENLIVEX ANNOUNCES DUAL LISTING ON THE TEL-AVIV STOCK EXCHANGE

News
June 05, 2019

These Israeli companies are trying to solve tough medical issues

News
May 27, 2019

שילוב מחקר מוביל, תשתיות וידע במרפאות ובמעבדות בית החולים הדסה

News
March 11, 2019

הסטארט-אפ של קבוצת הקנאביס שמשחזר רקמות הרוסות

News
July 31, 2018

Antiseptic Materials Startup Nobio Raises $3.6 Million

News
July 12, 2018

Hadassah doctors team up with Azrieli college engineers to co-develop medical devices

News
May 27, 2018

Recipharm and Hadasit partner to deliver seamless and clinical services

News
March 21, 2018

BioTime Announces DSMB Approval to Proceed to Cohort 4 of the OpRegen® Clinical Trial

News
March 21, 2018

Immuron Reports Positive Results in NASH Clinical Trial

News
September 27, 2017

Immuron Highlights Recent Milestones in Quest to Effectively Treat Multiple Forms of Fatty Liver Diseases That Impact Millions

News
September 27, 2017

Israeli immunotherapy co Enlivex Therapeutics raising $10m

News
September 19, 2017

Enlivex Therapeutics Announces Closing Of USD 8 Million Series B Round Led by Korea Investment Partners (KIP) & Hadasit Bio Holdingings Ltd. (HBL)

News
August 27, 2017

Fidmi Medical Raises US$2 Million from B. Braun Melsungen AG

News
August 02, 2017

Hadasit Bio-Holdings (HBL) and BioTime Complete Shares Swap Transaction in Cellcure Neurosciences